KALV
KalVista Pharmaceuticals Inc

3,119
Mkt Cap
$852.21M
Volume
1.22M
52W High
$17.28
52W Low
$7.30
PE Ratio
-4.22
KALV Fundamentals
Price
$16.81
Prev Close
$16.86
Open
$16.70
50D MA
$12.53
Beta
0.96
Avg. Volume
1.43M
EPS (Annual)
-$3.69
P/B
50.13
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Stempoint Capital LP Cuts Stock Position in KalVista Pharmaceuticals, Inc. $KALV
Stempoint Capital LP trimmed its stake in shares of KalVista Pharmaceuticals, Inc. (NASDAQ:KALV - Free Report) by 20.6% during the 2nd quarter, according to the company in its most recent Form 13F...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
KalVista Pharmaceuticals (NASDAQ:KALV) CEO Sells $120,423.94 in Stock
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV - Get Free Report) CEO Benjamin Palleiko sold 7,294 shares of the firm's stock in a transaction dated Monday, December 8th. The shares were sold at an...
MarketBeat·2d ago
News Placeholder
KalVista Pharmaceuticals (NASDAQ:KALV) Upgraded by Wall Street Zen to "Hold" Rating
Wall Street Zen raised KalVista Pharmaceuticals from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·6d ago
News Placeholder
KalVista Pharmaceuticals (NASDAQ:KALV) Receives Buy Rating from Needham & Company LLC
Needham & Company LLC reiterated a "buy" rating and issued a $28.00 price objective on shares of KalVista Pharmaceuticals in a report on Thursday...
MarketBeat·6d ago
News Placeholder
KalVista Pharmaceuticals (NASDAQ:KALV) Receives Buy Rating from Needham & Company LLC
Needham & Company LLC reiterated a "buy" rating and issued a $28.00 price objective on shares of KalVista Pharmaceuticals in a report on Thursday...
MarketBeat·6d ago
News Placeholder
KalVista Pharmaceuticals, Inc. $KALV Shares Purchased by Stonepine Capital Management LLC
Stonepine Capital Management LLC boosted its holdings in shares of KalVista Pharmaceuticals, Inc. (NASDAQ:KALV - Free Report) by 364.0% in the second quarter, according to its most recent disclosure...
MarketBeat·6d ago
News Placeholder
KalVista Pharmaceuticals, Inc. $KALV Shares Purchased by Stonepine Capital Management LLC
Stonepine Capital Management LLC boosted its holdings in shares of KalVista Pharmaceuticals, Inc. (NASDAQ:KALV - Free Report) by 364.0% in the second quarter, according to its most recent disclosure...
MarketBeat·6d ago
News Placeholder
Schroder Investment Management Group Has $6.27 Million Stock Holdings in KalVista Pharmaceuticals, Inc. $KALV
Schroder Investment Management Group decreased its position in KalVista Pharmaceuticals, Inc. (NASDAQ:KALV - Free Report) by 36.1% in the 2nd quarter, according to the company in its most recent...
MarketBeat·6d ago
News Placeholder
Schroder Investment Management Group Has $6.27 Million Stock Holdings in KalVista Pharmaceuticals, Inc. $KALV
Schroder Investment Management Group decreased its position in KalVista Pharmaceuticals, Inc. (NASDAQ:KALV - Free Report) by 36.1% in the 2nd quarter, according to the company in its most recent...
MarketBeat·6d ago
News Placeholder
Schroder Investment Management Group Has $6.27 Million Stock Holdings in KalVista Pharmaceuticals, Inc. $KALV
Schroder Investment Management Group decreased its position in KalVista Pharmaceuticals, Inc. (NASDAQ:KALV - Free Report) by 36.1% in the 2nd quarter, according to the company in its most recent...
MarketBeat·6d ago

Latest KALV News

View

Advertisement|Remove ads.

Advertisement|Remove ads.